BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34310027)

  • 1. Predicting fever in neutropenia with safety-relevant events in children undergoing chemotherapy for cancer: The prospective multicenter SPOG 2015 FN Definition Study.
    Lavieri L; Koenig C; Bodmer N; Agyeman PKA; Scheinemann K; Ansari M; Roessler J; Ammann RA
    Pediatr Blood Cancer; 2021 Dec; 68(12):e29253. PubMed ID: 34310027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study.
    Agyeman P; Aebi C; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Beck Popovic M; Leibundgut K; Bodmer N; Ammann RA
    Pediatr Infect Dis J; 2011 Jul; 30(7):e114-9. PubMed ID: 21394050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome prediction in pediatric fever in neutropenia: Development of clinical decision rules and external validation of published rules based on data from the prospective multicenter SPOG 2015 FN definition study.
    Santschi M; Ammann RA; Agyeman PKA; Ansari M; Bodmer N; Brack E; Koenig C
    PLoS One; 2023; 18(8):e0287233. PubMed ID: 37531403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study.
    Ammann RA; Bodmer N; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Popovic MB; Lüthy AR; Aebi C
    J Clin Oncol; 2010 Apr; 28(12):2008-14. PubMed ID: 20231680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk prediction of fever in neutropenia in children with cancer: a step towards individually tailored supportive therapy?
    Wicki S; Keisker A; Aebi C; Leibundgut K; Hirt A; Ammann RA
    Pediatr Blood Cancer; 2008 Dec; 51(6):778-83. PubMed ID: 18726920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study.
    Agyeman P; Kontny U; Nadal D; Leibundgut K; Niggli F; Simon A; Kronenberg A; Frei R; Escobar H; Kühne T; Beck-Popovic M; Bodmer N; Ammann RA
    Pediatr Infect Dis J; 2014 Sep; 33(9):e219-25. PubMed ID: 24618935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to antibiotics is unrelated to outcome in pediatric patients with fever in neutropenia presenting without severe disease during chemotherapy for cancer.
    Koenig C; Kuehni CE; Bodmer N; Agyeman PKA; Ansari M; Roessler J; von der Weid NX; Ammann RA
    Sci Rep; 2022 Aug; 12(1):14028. PubMed ID: 35982121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 39·0°C versus 38·5°C ear temperature as fever limit in children with neutropenia undergoing chemotherapy for cancer: a multicentre, cluster-randomised, multiple-crossover, non-inferiority trial.
    Koenig C; Bodmer N; Agyeman PKA; Niggli F; Adam C; Ansari M; Eisenreich B; Keller N; Leibundgut K; Nadal D; Roessler J; Scheinemann K; Simon A; Teuffel O; von der Weid NX; Zeller M; Zimmermann K; Ammann RA
    Lancet Child Adolesc Health; 2020 Jul; 4(7):495-502. PubMed ID: 32497520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric patients at risk for fever in chemotherapy-induced neutropenia in Bern, Switzerland, 1993-2012.
    von Allmen AN; Zermatten MG; Leibundgut K; Agyeman P; Ammann RA
    Sci Data; 2018 Mar; 5():180038. PubMed ID: 29534058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different fever definitions and the rate of fever and neutropenia diagnosed in children with cancer: a retrospective two-center cohort study.
    Binz P; Bodmer N; Leibundgut K; Teuffel O; Niggli FK; Ammann RA
    Pediatr Blood Cancer; 2013 May; 60(5):799-805. PubMed ID: 23193083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiology and clinical course of febrile neutropenia in children with cancer.
    Hakim H; Flynn PM; Knapp KM; Srivastava DK; Gaur AH
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):623-9. PubMed ID: 19644403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients.
    Schlapbach LJ; Aebi C; Otth M; Luethy AR; Leibundgut K; Hirt A; Ammann RA
    Pediatr Blood Cancer; 2007 Jul; 49(1):11-6. PubMed ID: 17143875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
    Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
    Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients.
    Schlapbach LJ; Aebi C; Otth M; Leibundgut K; Hirt A; Ammann RA
    Pediatr Infect Dis J; 2007 Nov; 26(11):989-94. PubMed ID: 17984804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.
    Alali M; Mayampurath A; Dai Y; Bartlett AH
    Sci Rep; 2022 May; 12(1):7429. PubMed ID: 35523855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.
    Ammann RA; Hirt A; Lüthy AR; Aebi C
    Med Pediatr Oncol; 2003 Nov; 41(5):436-43. PubMed ID: 14515382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Episodes of fever in neutropenia in pediatric patients with cancer in Bern, Switzerland, 1993-2012.
    Zermatten MG; Koenig C; von Allmen A; Agyeman P; Ammann RA
    Sci Data; 2019 Jan; 6():180304. PubMed ID: 30644854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study.
    Brack E; Bodmer N; Simon A; Leibundgut K; Kühne T; Niggli FK; Ammann RA
    Pediatr Blood Cancer; 2012 Sep; 59(3):423-30. PubMed ID: 22271702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia.
    Ammann RA; Hirt A; Lüthy AR; Aebi C
    Pediatr Infect Dis J; 2004 Jan; 23(1):61-7. PubMed ID: 14743049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious medical complications in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study.
    Lüthi F; Leibundgut K; Niggli FK; Nadal D; Aebi C; Bodmer N; Ammann RA
    Pediatr Blood Cancer; 2012 Jul; 59(1):90-5. PubMed ID: 21837771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.